Scottsdale, Arizona, Apr 28: SimonMed, the nation’s largest independent outpatient imaging provider, today announced the enterprise-wide deployment of AIRS Medical’s SwiftMR™, an FDA-cleared AI solution for MRI enhancement, across its nationwide network.
This decision follows a comprehensive evaluation of leading MRI AI platforms as part of SimonMed’s broader strategy to elevate imaging quality, improve access, and deliver a more consistent, patient-centered diagnostic experience at scale.
As MRI demand continues to grow, imaging providers face increasing pressure to deliver faster exams without compromising diagnostic accuracy. SimonMed’s adoption of SwiftMR reflects a deliberate move to raise the standard across its multi-vendor MRI fleet—improving image clarity, reducing scan times, and enhancing overall workflow efficiency.
“AI in imaging has reached a point where it can meaningfully elevate both the quality and accessibility of care, but only if deployed thoughtfully at scale,” said Dr. Sean Raj, MD, Chief Medical Officer and Chief Innovation Officer of SimonMed.
“We rigorously evaluated every major solution in the market, and this was a clear decision. We chose AIRS Medical because their technology consistently delivered high-quality images, the most reliable performance across diverse scanner environments, and the greatest potential to improve the patient experience. Shorter scan times, clearer images, and more consistent studies across our network directly translate into better, faster answers for patients. That’s the bar we hold ourselves to.”
With one of the largest and most diverse outpatient imaging infrastructures in the United States, SimonMed requires solutions that perform reliably across different scanner types, manufacturers, and clinical environments. SwiftMR’s vendor-neutral architecture enables consistent deployment without the need for additional hardware investment.
The deployment of SwiftMR is part of SimonMed’s broader strategy to integrate advanced AI across its imaging platform, supporting both traditional diagnostic workflows and its expanding preventive and longevity-focused programs.
By combining scale, clinical expertise, and real-world data, SimonMed continues to lead the development and deployment of AI solutions that are not only technically advanced, but clinically meaningful and accessible to patients nationwide.
Leave a Reply